| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +10.3 M | 100% | $7.28 | +$74.9 M |
| Sells | 0 | ||||
| Net | +3 | +10.3 M | 100% | +$74.9 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Wayne P. Rothbaum | Director | $258 M | +$72.3 M | +39% | Mar 1, 2024 |
| Merrill A. Mcpeak | Director | $5.66 M | +$2.34 M | +70.6% | Mar 1, 2024 |
| Frederick G. Vogt | Interim CEO & General Counsel | $2.1 M | Jun 3, 2024 | ||
| Iain Dukes | Director | $1.32 M | +$293 K | +28.5% | Jun 11, 2024 |
| Friedrich Graf | Chief Medical Officer | $601 K | Jun 3, 2024 | ||
| Igor Bilinsky | Chief Operating Officer | $539 K | Jun 3, 2024 | ||
| Wendy L. Dixon | Director | $469 K | Jun 10, 2022 | ||
| Jean-Marc Bellemin | Chief Financial Officer | $429 K | Mar 1, 2024 | ||
| Wendy L. Yarno | Director | $413 K | Jun 11, 2024 | ||
| Ryan Maynard | Director | $413 K | Jun 11, 2024 | ||
| Michael Weiser | Director | $413 K | Jun 11, 2024 | ||
| Athena Countouriotis | Director | $413 K | Jun 11, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|